[与造血干细胞移植相关的克隆性血液形成的研究进展]
1The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis Under Ministry of Health, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou 215006, China.
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
|February 9, 2026
概括
与DNMT3A等突变相关的克隆性造血可能会在造血干细胞移植 (HSCT) 后恶化结果. 了解这些遗传因素是提高HSCT成功率的关键.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 高通量测序增加了对各种疾病中克隆性血液形成的关注.
- 造血干细胞移植 (HSCT) 改善了血液病的存活率,但具有不良结果.
- 不良结果的机制,如移植对宿主疾病和HSCT后复发,尚未完全理解.
研究的目的:
- 系统地审查基因因素,原因,进展和预后影响的克隆性血液形成在HSCT.
- 为探索与HSCT相关的克隆血液形成机制提供理论基础.
- 帮助优化HSCT治疗方案.
主要方法:
- 对最近的研究进行系统审查.
- 对遗传因素和诱因的分析.
- 评估研究进展和对预后的影响.
主要成果:
- 克隆性血液形成相关的基因 (例如,DNMT3A,PPM1D) 与不良的HSCT预后有关.
- 遗传因素和诱导与HSCT相关的克隆性血液形成正在被阐明.
- 研究强调了克隆性血液形成与HSCT结果之间的联系.
结论:
- 克隆性血液形成在HSCT结果中起着重要作用.
- 对遗传因素的进一步研究可以导致更好的HSCT策略.
- 了解克隆性血液形成对于改善HSCT后患者预后至关重要.
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.9K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.9K
Regulation of Hematopoietic Stem Cells
4.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.1K
Hematopoiesis
9.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.1K
Overview of Hematopoiesis
9.7K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
9.7K
T Cell Activation and Clonal Selection
16.2K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.2K
Induced Pluripotent Stem Cells
28.1K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K


